VI-RADS 在经尿道电切术后预测肌层浸润性膀胱癌的表现:单中心回顾性分析
该单中心回顾性研究纳入 2016 至 2020 年间经尿道膀胱肿瘤电切术(TURBT)后行 MRI 且 3 个月内接受膀胱切除术的 70 例膀胱尿路上皮癌患者,由三名放射科医生盲法独立评分。VI-RADS 诊断肌层浸润性膀胱癌的 AUC 为 0.67–0.77,敏感度中等、特异度低,读者间一致性中等。
要点
- TURBT 术后 VI-RADS 诊断 MIBC 的 AUC 为 0.67–0.77,三名读者间无统计差异。
- VI-RADS ≥3 分诊断 MIBC 敏感度 81.3–93.8%,特异度仅 36.8–55.3%。
- VI-RADS ≥4 分诊断 MIBC 敏感度 78.1–81.3%,特异度 47.4–68.4%。
核心结论
- TURBT 术后 VI-RADS 检测 MIBC 的敏感度和准确率中等、特异度低,读者间一致性中等。
研究设计与样本
- IRB 批准、符合 HIPAA 的单中心回顾性研究,纳入 2016 至 2020 年 TURBT 后行 MRI 且 3 个月内无 MRI 后治疗即行膀胱切除术的膀胱尿路上皮癌患者 70 例(平均年龄 68 岁±11,范围 39–85 岁,男 58 例)。三名放射科医生盲法独立阅片并赋 VI-RADS 评分。
诊断标准与关键数值
- 以膀胱切除病理为参考,VI-RADS ≥3 分诊断 MIBC 的敏感度 81.3–93.8%、特异度 36.8–55.3%、PPV 55.6–60.5%、NPV 77.3–87.5%、准确率 62.9–67.1%;VI-RADS ≥4 分敏感度 78.1–81.3%、特异度 47.4–68.4%、PPV 55.6–67.6%、NPV 72.0–78.8%、准确率 61.4–72.9%;AUC 0.67–0.77,读者间两两比较 p 值 0.06、0.08、0.97。
临床应用与阅片要点
- 31/70(44%)患者在 MRI 前接受过治疗,该亚组 VI-RADS 表现与总体无统计差异(p ≥ 0.16)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess VIRADS performance and inter-reader agreement for detecting muscle-invasive bladder cancer (MIBC) following transurethral resection of bladder tumor (TURBT).
METHODS: An IRB-approved, HIPAA-compliant, retrospective study from 2016 to 2020 included patients with bladder urothelial carcinoma who underwent MRI after TURBT, and cystectomy within 3 months without post-MRI treatments. Three radiologists blinded to pathology results independently reviewed MR images and assigned a VI-RADS score. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of VI-RADS were assessed for diagnosing MIBC using VI-RADS scores ≥ 3 and ≥ 4. Inter-reader agreement was assessed using Gwet's agreement coefficient (AC) and percent agreement.
RESULTS: The cohort consisted of 70 patients (mean age, 68 years ± 11 [SD]; range 39-85; 58 men) and included 32/70 (46%) with MIBC at cystectomy. ROC analysis revealed an AUC ranging from 0.67 to 0.77 and no pairwise statistical difference between readers (p-values, 0.06, 0.08, 0.97). Percent sensitivity, specificity, PPV, NPV and accuracy for diagnosing MIBC for the three readers ranged from 81.3-93.8, 36.8-55.3, 55.6-60.5, 77.3-87.5, and 62.9-67.1 respectively for VI-RADS score ≥ 3, and 78.1-81.3, 47.4-68.4, 55.6-67.6, 72.0-78.8 and 61.4-72.9 respectively for VI-RADS score ≥ 4. Gwet's AC was 0.63 [95% confidence interval (CI): 0.49,0.78] for VI-RADS score ≥ 3 with 79% agreement [95% CI 72,87] and 0.54 [95%CI 0.38,0.70] for VI-RADS score ≥ 4 with 76% agreement [95% CI 69,84]. VIRADS performance was not statistically different among 31/70 (44%) patients who received treatments prior to MRI (p ≥ 0.16).
CONCLUSION: VI-RADS had moderate sensitivity and accuracy but low specificity for detection of MIBC following TURBT, with moderate inter-reader agreement.
引用
- Chai JL, Roller LA, Liu X, et al. Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis. Abdom Radiol (NY). 2024. PMID: 38502214. doi:10.1007/s00261-024-04245-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。